Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
NMLSF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Restart Life Sciences Launches HC Protein+ Products Online and Advances AI-Driven E-Commerce Strategy
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the commercial online launch of its new HC…
Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its premium functional food brand, Holy…
Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods…
Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada's Digital Marketplace
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foo…
Healthcare Breakthroughs: KZR, NMLSF, AGRX, LMLLF Report Latest Advances in Novel Therapeutics for Inflammatory Diseases, Oncology, and Autism
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Kezar Life Sciences (NASDAQ: KZR), Nova Mentis Life S…
CEO’s of BOXD, NEXCF, NMLSF, and SMFL Driving Innovation, and Revenue Growth Opportunities with Innovation in Web 3.0, E-Commerce, Baby Nutrition and Psychedelics-based Therapies
NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Boxed, Inc. (NYSE: BOXD), NexTech AR Solutions (OTC:…
Healthcare Breakthroughs: NVAX, MITO, LMLLF, NMLSF; Life Sciences Leaders Report Latest Advances in Vaccines, Novel Therapeutics for Autism, Neurodegenerative, Oncology, and Glaucoma
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), N…
BioMed Leaders KRBP, NMLSF, VERU, AIMLF Report Latest Advances in Vaccines, Novel Therapeutics for Oncology, and Autism and HealthTech AI
NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Kiromic BioPharma (NASDAQ: KRBP), Nova Mentis Life Sci…
BioMed Stocks On the Move: PDSB, NMLSF, TNXP, AIMLF; Leaders Report Latest Advances in Antiviral Vaccines, Novel Therapeutics for Oncology, and Autism and HealthTech Wearables
NEW YORK, June 02, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Tonix Pharmaceuticals (NASDAQ: TNXP), Nova Mentis Lif…
BioMed Stocks On the Move: GeoVax Labs, Nova Mentis, SIGA and PharmaDrug; Life Sciences Leaders Report Latest Advances in Antiviral Vaccines, and Novel Therapeutics for Oncology, Glaucoma and Autism
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: SIGA Technologies (NASDAQ: SIGA), Nova Mentis Life Sci…
BioMed Stocks On the Move: Nova Mentis, PolarityTE, Veru, and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, Novel Therapeutics for Oncology, COVID, Glaucoma, and Autism
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Po…
BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Ver…
BioMed Momentum: AGRX, NMLSF, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Oncology, Glaucoma, and Autism
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences…
Next Super Stocks on the Move: NEXCF, NMLSF, OGGFF, LMLLF; Driving Disruptive Innovation with Explosive Revenue Growth Potential in Biopharma, E-Commerce, Metaverse, and Plant-Based Brands
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK…
Healthcare Breakthroughs: AGRX, NMLSF, BBI, LMLLF; BioMed Leaders Report Latest Advances in New Drug Development for Women’s Health, Autism, Glaucoma, and Cancer Therapeutics
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Brickell Biotech (NASDAQ: BBI), Nova Mentis Life Sci…
Next Super Stocks on the Move: NMLSF, NEXCF, OGGFF, MKTDF; Leading Innovation in Carbon Credits, Metaverse, Plant-Based Brands, and Biopharma.
NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK…
BioMed Momentum: VERU, NMLSF, PHRX, CRXT; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism
NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (…
BioMed Stocks On the Move: Nova Mentis, PolarityTE, Biodesix and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, New Drugs for Cancers, Glaucoma, and Autism, and Diagnostics.
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: PolarityTE, Inc. (NASDAQ: PTE) Nova Mentis Life Scie…
Healthcare Breakthroughs: Veru, Nova Mentis, Phio, and PharmaDrug; Visionary CEOs Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA),…
BioMed Leaders: Hoth Therapeutics, Nova Mentis Life Sciences, Tonix Pharmaceuticals, and MedAvail; Visionary CEOs Report Latest Advances in Novel Therapeutics for Autism, Cancer, and Fibromyalgia, and Drug Affordability.
NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Hoth Therapeutics (NASDAQ: HOTH), Nova Mentis Life S…
Nova Mentis to Produce Psilocybin Capsules for Phase 2A Clinical Study
Manufacturing Contract with the Toronto Institute of Pharmaceutical Technology VANCOUVER, BC, April 7, 2022 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company an…
Nova Mentis Begins Enrollment in North American Autism Study
VANCOUVER, BC, March 23, 2022 /PRNewswire/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and com…